lomustine
Drug Details
- Generic Name
- lomustine
- Brand Names
- Gleostine
- Application Number
- NDA017588
- Sponsor
- NextSource Biotechnology, LLC
- NDC Codes
- 6
- Dosage Forms
- CAPSULE, GELATIN COATED
- Routes
- ORAL
- Active Ingredients
- LOMUSTINE
Indications and Usage
1 INDICATIONS AND USAGE Gleostine is an alkylating drug indicated for the treatment of patients with: Brain tumors, primary and metastatic, following appropriate surgical and/or radiotherapeutic procedures. ( 1 ) Hodgkin's lymphoma in combination with other chemotherapies, following disease progression with initial chemotherapy. ( 1 ) 1.1 Brain Tumors Gleostine is indicated for the treatment of patients with primary and metastatic brain tumors following appropriate surgical and/or radiotherapeutic procedures. 1.2 Hodgkin's Lymphoma Gleostine is indicated as a component of combination chemotherapy for the treatment of patients with Hodgkin's lymphoma whose disease has progressed following initial chemotherapy.